Paraplegia subsequent to administration of tissue plasminogen activator and intravenous heparin following myocardial infarction--a case report.
A case involving spinal epidural hematoma following tissue plasminogen activator and intravenous heparin therapy administered after acute myocardial infarction is reported here. The symptoms of spinal epidural hematoma following thrombolytic therapy are outlined and a recommended course of action for arriving at a definitive diagnosis of suspected epidural hematoma is provided.
DePorto
R
R
Department of Rehabilitation Medicine, New York University Medical Center, New York, USA.
Ahn
J H
JH
Gianutsos
J G
JG
D000368:Aged; D004359:Drug Therapy, Combination; D006407:Hematoma, Epidural, Cranial / Q000139:chemically induced* / Q000175:diagnosis; D006493:Heparin / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D007262:Infusions, Intravenous; D008279:Magnetic Resonance Imaging; D008297:Male; D009203:Myocardial Infarction / Q000188:drug therapy*; D010264:Paraplegia / Q000139:chemically induced* / Q000175:diagnosis; D015912:Thrombolytic Therapy; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage / Q000009:adverse effects*
D006493:Heparin; D010959:Tissue Plasminogen Activator